365NEWSX
365NEWSX
Subscribe

Welcome

Alzheimer's drug lecanemab: Your questions answered on breakthrough medicine - BBC

Alzheimer's drug lecanemab: Your questions answered on breakthrough medicine - BBC

Alzheimer's drug lecanemab: Your questions answered on breakthrough medicine - BBC
Nov 30, 2022 2 mins, 16 secs

With the BBC's health and science correspondent James Gallagher | Read more about the new drug here.

We're bringing our Q&A on a breakthrough drug to treat Alzheimer's to an end shortly - thanks for sending us your questions.

Thanks also to our health and science correspondent James Gallagher for providing plenty of really useful answers.

And if you want to know more, read on about on lecanemab, the first drug to slow the destruction of the brain in Alzheimer's, here.

James Gallagher.

Health and science correspondent.

The drug may become.

Health and science correspondent.

The idea of slowing the disease down in the earliest stages.

Health and science correspondent.

This drug works.

A man diagnosed with early onset Alzheimer's has hailed the research breakthrough on the lecanemab drug as “wonderful news”, adding that early intervention with the disease is crucial.

Health and science correspondent.

The drug has been developed by two pharmaceutical companies:.

Health and science correspondent.

drug will help no-one unless people can be diagnosed with Alzheimer’s in the.

earliest stage of the disease when the drug can still make a difference.

Health and science correspondent?

Brian, 84, from Shropshire, says his wife Doreen has been having "early cognitive impairment" and her close relatives have had the disease - he asks whether she's therefore more likely to get the drug.

"For anyone dealing with the hereditary side of Alzheimer's, it's an amazing breakthrough," she says

Health and science correspondent

Lots of people have been asking this

Health and science correspondent

It works best if people are diagnosed in the earliest stages

The main thing, she said, is that the NHS isn’t ready to deliver the drug as it currently stands

Health and science correspondent

Health and science correspondent

The best guess comes from a similar drug called aducanumab,

Before we kick off the questions, let's recap what this new drug is and how it works

Lecanemab attacks the sticky gunge - called beta amyloid - that builds up in the brains of people with Alzheimer's

While it is the first drug to slow the destruction of the brain in Alzheimer's, it has only a small effect and its impact on people's daily lives is debated

The drug works in the early stages of the disease, so most would miss out without a revolution in spotting it

Good afternoon and thanks for joining us as we answer your questions about the new breakthrough drug to treat Alzheimer's

Lecanemab is the first drug to slow the destruction of the brain in people with Alzheimer's and has been heralded as "momentous", although its effect is small

What does this development mean and what impact will it actually have on people with Alzheimer's

The BBC's health and science correspondent James Gallagher will be answering your questions - stay with us

Summarized by 365NEWSX ROBOTS

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED